(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.

The three biggest winners today are ADC SIIC, ADOCIA, and BERGENBIO.

Financial Asset	Price	Change	Updated (EST)
ADC SIIC (ALDV.PA)	0.07	17.5%	2023-08-28 12:30:13
ADOCIA (ADOC.PA)	14.48	14.74%	2023-08-28 12:30:23
BERGENBIO (BGBIO.OL)	0.12	11.45%	2023-08-28 12:18:29
MAGNORA (MGN.OL)	35.10	10.38%	2023-08-28 12:25:19
LAVIDE HOLDING (LVIDE.AS)	0.22	9.8%	2023-08-28 12:03:49
BENEVOLENTAI (BAI.AS)	1.15	9.52%	2023-08-28 12:01:12
CAMPINE (CAMB.BR)	59.50	9.17%	2023-08-28 12:07:12
HAVILA SHIPPING (HAVI.OL)	10.06	5.89%	2023-08-28 12:24:29
VISTIN PHARMA (VISTN.OL)	22.20	5.71%	2023-08-28 12:29:17
FONCIERE INEA (INEA.PA)	38.00	5.56%	2023-08-28 12:42:12

The three biggest losers today are PIERRE VAC BSA ACT, BW OFFSHORE LTD, and DGB GROUP N.V..

Financial Asset	Price	Change	Updated (EST)
PIERRE VAC BSA ACT (VACBS.PA)	0.14	-15%	2023-08-28 12:49:44
BW OFFSHORE LTD (BWO.OL)	25.42	-12.1%	2023-08-28 12:18:57
DGB GROUP N.V. (DGB.AS)	0.44	-9.19%	2023-08-28 12:02:07
SODITECH (SEC.PA)	1.50	-8.54%	2023-08-28 12:57:01
SOLSTAD OFFSHORE (SOFF.OL)	17.66	-7.97%	2023-08-28 12:28:14
JINHUI SHIPP TRANS (JIN.OL)	5.95	-6.74%	2023-08-28 12:24:49
TERACT (TRACT.PA)	3.95	-5.95%	2023-08-28 12:57:48
PGS (PGS.OL)	7.28	-5.82%	2023-08-28 12:27:00
NAPATECH (NAPA.OL)	9.12	-5.79%	2023-08-28 12:25:43
MDXHEALTH (MDXH.BR)	0.31	-5.56%	2023-08-28 12:12:43

Winners today

1. ADC SIIC (ALDV.PA)

17.5% Price Change

Alliance Developpement Capital SIIC (ADC SIIC) is a publicly owned real estate investment firm. The firm specializes in owning and managing residential real estate properties. It primarily invests in properties in Paris and its suburbs. The firm was formerly known as AD Capital SA. Alliance Developpement Capital is based in Saint-Josse-Ten-Noode, Belgium.

CAC 40 ended the session with ADC SIIC jumping 17.5% to €0.07 on Monday, after five sequential sessions in a row of losses. CAC 40 jumped 1.32% to €7,324.71, following the last session’s upward trend on what was an all-around up trend trading session today.

Earnings Per Share

As for profitability, ADC SIIC has a trailing twelve months EPS of €-0.01.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -1.87%.

More news about ADC SIIC.

2. ADOCIA (ADOC.PA)

14.74% Price Change

Adocia SA, a clinical-stage biotechnology company, researches and develops formulations of pre-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. Its proprietary BioChaperone technological platform provides molecular delivery of therapeutic proteins. The company's clinical product pipeline includes insulin formulations, such as BioChaperone Lispro U100 and U200, which are ultra-rapid formulations based on rapid insulin lispro; BioChaperone Combo, a combination of acting insulin glargine and rapid-acting insulin lispro; BioChaperone LisPram, a combination of prandial insulin with pramlintide; and BioChaperone Glucagon, an aqueous formulation of human glucagon for the treatment of hypoglycemia, as well as M1Pram, a metabolite of insulin glargine and pramlintide. Its preclinical pipeline includes products for the treatment of diabetes and obesity comprising AdoShell Islets, an implant containing islets of Langerhans; AdOral Sema, an oral delivery of semaglutide; and BioChaperone GluExe, a combination of glucagon and exenatide. The company has a strategic alliance with Tonghua Dongbao Pharmaceutical Co., Ltd. to develop and commercialize BioChaperone Lispro and BioChaperone Combo in China and other Asian and Middle Eastern territories. Adocia SA was incorporated in 2005 and is headquartered in Lyon, France.

CAC 40 ended the session with ADOCIA rising 14.74% to €14.48 on Monday, following the last session’s downward trend. CAC 40 rose 1.32% to €7,324.71, following the last session’s upward trend on what was an all-around up trend trading session today.

Earnings Per Share

As for profitability, ADOCIA has a trailing twelve months EPS of €-0.89.

Revenue Growth

Year-on-year quarterly revenue growth grew by 96.9%, now sitting on 17.36M for the twelve trailing months.

Moving Average

ADOCIA’s worth is way above its 50-day moving average of €4.06 and way higher than its 200-day moving average of €3.59.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ADOCIA’s stock is considered to be oversold (<=20).

Volume

Today’s last reported volume for ADOCIA is 349874 which is 116.54% above its average volume of 161572.

More news about ADOCIA.

3. BERGENBIO (BGBIO.OL)

11.45% Price Change

BerGenBio ASA, a clinical-stage biopharmaceutical company, engages in development of novel medicines to treat immune-evasive, drug resistant, and metastatic cancers; and respiratory diseases. It develops bemcentinib, an oral once-a-day inhibitor of AXL receptor tyrosine kinase, which is in Phase 1b/2a clinical trial to treat non-small cell lung cancer, and Phase 2 clinical trial to treat acute myeloid leukemia and COVID-19. Bemcentinib is also being studied for glioblastoma, 2L lung cancer, melanoma, pancreatic cancer, and mesothelioma. In addition, the company is developing tilvestamab, an anti-AXL function-blocking monoclonal antibody that is in Phase 1b clinical trial for the treatment of ovarian cancer; and mipasetamab uzoptirine, which is in Phase 1 clinical trial for the treatment of solid tumors. It has a collaboration agreement with Merck & Co. for clinical trials. The company was incorporated in 2007 and is based in Bergen, Norway.

Oslo Børs Benchmark Index_GI ended the session with BERGENBIO jumping 11.45% to €0.12 on Monday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI rose 1.21% to €1,246.85, following the last session’s upward trend on what was an all-around positive trend exchanging session today.

Earnings Per Share

As for profitability, BERGENBIO has a trailing twelve months EPS of kr-2.83.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -179.58%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

BERGENBIO’s EBITDA is -2.91.

Volume

Today’s last reported volume for BERGENBIO is 74164100 which is 136% above its average volume of 31425400.

Volatility

BERGENBIO’s last week, last month’s, and last quarter’s current intraday variation average was 5.57%, 0.37%, and 6.30%.

BERGENBIO’s highest amplitude of average volatility was 16.40% (last week), 5.43% (last month), and 6.30% (last quarter).

Yearly Top and Bottom Value

BERGENBIO’s stock is valued at kr0.12 at 22:40 EST, way under its 52-week high of kr13.03 and way higher than its 52-week low of kr0.08.

More news about BERGENBIO.

4. MAGNORA (MGN.OL)

10.38% Price Change

Magnora ASA operates as a renewable energy development company. It primarily focuses on developing wind and solar photovoltaic (PV) projects. The company also hold license agreements with the Dana Western Isles and Shell Penguins FPSO. It serves oil companies and marine contractors in the United Kingdom, Norway, and Sweden. The company was formerly known as Sevan Marine ASA and changed its name to Magnora ASA in October 2018. Magnora ASA was incorporated in 2001 and is based in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with MAGNORA jumping 10.38% to €35.10 on Monday while Oslo Børs Benchmark Index_GI rose 1.21% to €1,246.85.

Earnings Per Share

As for profitability, MAGNORA has a trailing twelve months EPS of kr3.96.

PE Ratio

MAGNORA has a trailing twelve months price to earnings ratio of 8.86. Meaning, the purchaser of the share is investing kr8.86 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 59.67%.

Volatility

MAGNORA’s last week, last month’s, and last quarter’s current intraday variation average was 0.40%, 0.39%, and 1.72%.

MAGNORA’s highest amplitude of average volatility was 1.59% (last week), 1.49% (last month), and 1.72% (last quarter).

Volume

Today’s last reported volume for MAGNORA is 1022080 which is 421.96% above its average volume of 195814.

Yearly Top and Bottom Value

MAGNORA’s stock is valued at kr35.10 at 22:40 EST, above its 52-week high of kr32.50.

Moving Average

MAGNORA’s value is way above its 50-day moving average of kr29.53 and way higher than its 200-day moving average of kr24.93.

More news about MAGNORA.

5. LAVIDE HOLDING (LVIDE.AS)

9.8% Price Change

Lavide Holding N.V. does not have significant operations. Previously, it was engaged in the provision of integrated information technology solutions for medium to large-sized companies and organizations. The company was formerly known as Qurius N.V. and changed its name to Lavide Holding N.V. in July 2013. Lavide Holding N.V. was incorporated in 1998 and is based in Sluis, the Netherlands.

AEX-Index ended the session with LAVIDE HOLDING rising 9.8% to €0.22 on Monday while AEX-Index rose 1.14% to €741.76.

Earnings Per Share

As for profitability, LAVIDE HOLDING has a trailing twelve months EPS of €-0.04.

Moving Average

LAVIDE HOLDING’s worth is way under its 50-day moving average of €0.28 and way under its 200-day moving average of €0.33.

Volume

Today’s last reported volume for LAVIDE HOLDING is 2134 which is 66.66% below its average volume of 6401.

Volatility

LAVIDE HOLDING’s last week, last month’s, and last quarter’s current intraday variation average was a negative 3.99%, a negative 1.39%, and a positive 5.13%.

LAVIDE HOLDING’s highest amplitude of average volatility was 5.81% (last week), 6.69% (last month), and 5.13% (last quarter).

More news about LAVIDE HOLDING.

6. BENEVOLENTAI (BAI.AS)

9.52% Price Change

BenevolentAI S.A. operates as a clinical-stage AI-enabled drug discovery and development company. Its BenevolentAI platform powers in-house drug pipeline of drug programs. The company's therapeutic areas, include atopic dermatitis, ulcerative colitis, amyotrophic lateral sclerosis, glioblastoma multiforme, inflammatory bowel disease, antiviral, oncology, parkinson's disease, nonalcoholic steatohepatitis, fibrosis, inflammation, chronic kidney disease, and idiopathic pulmonary fibrosis. It has a collaboration with AstraZeneca to enhance understanding of complex disease biology and identify new targets. The company was founded in 2013 and is headquartered in London, United Kingdom.

AEX-Index ended the session with BENEVOLENTAI rising 9.52% to €1.15 on Monday, following the last session’s downward trend. AEX-Index rose 1.14% to €741.76, after two consecutive sessions in a row of losses, on what was an all-around bullish trend exchanging session today.

Earnings Per Share

As for profitability, BENEVOLENTAI has a trailing twelve months EPS of €-1.76.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -152.53%.

Volatility

BENEVOLENTAI’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.63%, a negative 2.41%, and a positive 3.97%.

BENEVOLENTAI’s highest amplitude of average volatility was 1.27% (last week), 4.34% (last month), and 3.97% (last quarter).

Yearly Top and Bottom Value

BENEVOLENTAI’s stock is valued at €1.15 at 22:40 EST, way under its 52-week high of €7.15 and above its 52-week low of €1.10.

More news about BENEVOLENTAI.

7. CAMPINE (CAMB.BR)

9.17% Price Change

Campine NV engages in the circular metals and specialty chemicals businesses. It manufactures lead alloys, as well as recovers, treats, and refines lead to produce refined lead ingots, as well as offers recycled batteries. The company also produces antimony trioxide used as flame retardants, polymerization catalysts, and pigment reagents, as well as PET catalysts; raw materials for pigments; and various types of polymer and plastic masterbatches. It operates in Belgium, Germany, Switzerland, France, Italy, Romania, the Netherlands, Turkey, Poland, the United Kingdom, rest of European countries, North America, Asia, and internationally. The company was formerly known as Compagnie Métallurgique de la Campine SA and changed its name to Campine NV in 1992. Campine NV was founded in 1912 and is based in Beerse, Belgium.

BEL 20 ended the session with CAMPINE rising 9.17% to €59.50 on Monday, following the last session’s upward trend. BEL 20 jumped 0.86% to €3,653.47, following the last session’s upward trend on what was a somewhat up trend exchanging session today.

Earnings Per Share

As for profitability, CAMPINE has a trailing twelve months EPS of €10.54.

PE Ratio

CAMPINE has a trailing twelve months price to earnings ratio of 5.65. Meaning, the purchaser of the share is investing €5.65 for every euro of annual earnings.

More news about CAMPINE.

8. HAVILA SHIPPING (HAVI.OL)

5.89% Price Change

Havila Shipping ASA, together with its subsidiaries, engages in the shipping business. It manages and operates offshore service vessels primarily in Norway, the United Kingdom, Denmark, Belgium, the Netherlands, Iceland, Tunisia, the Marshall Islands, and the United States. The company operates a fleet of 17 vessels, including 2 anchor handling vessels, 11 platform supply vessels, 1 rescue recovery vessel, and 3 subsea vessels. Its anchor handling tug and supply vessels are used for moving rigs and putting out anchors, as well as for supply services; platform supply vessels are used to carry goods, water, drilling mud, chemicals, etc. to and from the offshore installations; subsea vessels are used for under water construction work, as well as for support for under water operations; and rescue recovery vessels are used to offer security services, such as oil spill preparedness, fire protection, rescue operation, and recovery at oil installations. The company was founded in 2003 and is headquartered in Fosnavåg, Norway. Havila Shipping ASA is a subsidiary of Havila Holding AS.

Oslo Børs Benchmark Index_GI ended the session with HAVILA SHIPPING jumping 5.89% to €10.06 on Monday, after five sequential sessions in a row of losses. Oslo Børs Benchmark Index_GI jumped 1.21% to €1,246.85, following the last session’s upward trend on what was an all-around up trend trading session today.

Earnings Per Share

As for profitability, HAVILA SHIPPING has a trailing twelve months EPS of kr-3.88.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 157.28%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

HAVILA SHIPPING’s EBITDA is 10.77.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, HAVILA SHIPPING’s stock is considered to be overbought (>=80).

More news about HAVILA SHIPPING.

9. VISTIN PHARMA (VISTN.OL)

5.71% Price Change

Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, produces and sells active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for the pharmaceutical industry. The company was founded in 1969 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with VISTIN PHARMA jumping 5.71% to €22.20 on Monday, after three sequential sessions in a row of losses. Oslo Børs Benchmark Index_GI rose 1.21% to €1,246.85, following the last session’s upward trend on what was an all-around positive trend trading session today.

Earnings Per Share

As for profitability, VISTIN PHARMA has a trailing twelve months EPS of kr0.16.

PE Ratio

VISTIN PHARMA has a trailing twelve months price to earnings ratio of 138.75. Meaning, the purchaser of the share is investing kr138.75 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.32%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

VISTIN PHARMA’s EBITDA is 2.36.

More news about VISTIN PHARMA.

10. FONCIERE INEA (INEA.PA)

5.56% Price Change

Fonciere Inea S.A., a real estate investment company, engages in owning and managing business real estate properties in France. As of December 31, 2010, its property portfolio consisted of 111 buildings. The company was founded in 2005 and is based in Paris, France.

CAC 40 ended the session with FONCIERE INEA jumping 5.56% to €38.00 on Monday, following the last session’s upward trend. CAC 40 rose 1.32% to €7,324.71, following the last session’s upward trend on what was an all-around up trend trading session today.

Earnings Per Share

As for profitability, FONCIERE INEA has a trailing twelve months EPS of €3.84.

PE Ratio

FONCIERE INEA has a trailing twelve months price to earnings ratio of 9.9. Meaning, the purchaser of the share is investing €9.9 for every euro of annual earnings.

Volume

Today’s last reported volume for FONCIERE INEA is 2241 which is 870.13% above its average volume of 231.

More news about FONCIERE INEA.

Losers Today

1. PIERRE VAC BSA ACT (VACBS.PA)

-15% Price Change

CAC 40 ended the session with PIERRE VAC BSA ACT falling 15% to €0.14 on Monday while CAC 40 jumped 1.32% to €7,324.71.

Yearly Top and Bottom Value

PIERRE VAC BSA ACT’s stock is valued at €0.14 at 22:40 EST, under its 52-week high of €0.14 and above its 52-week low of €0.14.

More news about PIERRE VAC BSA ACT.

2. BW OFFSHORE LTD (BWO.OL)

-12.1% Price Change

BW Offshore Limited engages in the engineering of offshore production solutions in the Americas, Europe, Africa, Asia, and the Pacific. The company builds, owns, leases, and operates floating, production, storage, and offloading vessels (FPSOs) for oil and gas industries. It also provides engineering services. The company was founded in 1982 and is based in Hamilton, Bermuda.

Oslo Børs Benchmark Index_GI ended the session with BW OFFSHORE LTD dropping 12.1% to €25.42 on Monday while Oslo Børs Benchmark Index_GI rose 1.21% to €1,246.85.

Earnings Per Share

As for profitability, BW OFFSHORE LTD has a trailing twelve months EPS of kr6.99.

PE Ratio

BW OFFSHORE LTD has a trailing twelve months price to earnings ratio of 3.64. Meaning, the purchaser of the share is investing kr3.64 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.08%.

Moving Average

BW OFFSHORE LTD’s value is below its 50-day moving average of kr26.84 and under its 200-day moving average of kr27.05.

More news about BW OFFSHORE LTD.

3. DGB GROUP N.V. (DGB.AS)

-9.19% Price Change

DGB Group N.V. invests in, develops, and manages biodiversity and carbon offset, and nature-based projects for businesses and governments in the Netherlands and internationally. The company offers nature-based solutions comprising the management and use of nature for tackling social and environmental challenges; carbon offsetting projects for reducing carbon footprint of companies; and biodiversity protection and ecosystem services. It also provides ESG reporting and tree integration services. The company was formerly known as Verenigde Nederlandse Compagnie N.V. and changed its name to DGB Group N.V. in January 2018. DGB Group N.V. was founded in 1957 and is based in Haarlemmermeer, the Netherlands.

AEX-Index ended the session with DGB GROUP N.V. falling 9.19% to €0.44 on Monday, after two sequential sessions in a row of gains. AEX-Index rose 1.14% to €741.76, after two sequential sessions in a row of losses, on what was an all-around positive trend exchanging session today.

Earnings Per Share

As for profitability, DGB GROUP N.V. has a trailing twelve months EPS of €-0.11.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -5.92%.

Moving Average

DGB GROUP N.V.’s worth is way below its 50-day moving average of €0.50 and way below its 200-day moving average of €0.71.

More news about DGB GROUP N.V..

4. SODITECH (SEC.PA)

-8.54% Price Change

Soditech SA engages in the integration of mechanical, thermal, and electronic sub-assemblies in space, research, and defense fields in France. It designs structural sub-assemblies and integrates optical and thermal equipment, such as OSRs, SSMs, heaters, and heat pipes; designs and manufactures multi-layer insulation products; and designs, manufactures, and tests space harnesses on instruments or platforms. The company also provides calculation services, such as static, dynamic, thermal, and thermoelastic; designs assembly tools; and designs and produces super insulating multi-layer mattresses for ultra-vacuum areas. In addition, it develops, qualifies, manufactures, and tests embedded cabinets; and designs, assembles, and tests racks and test equipment racks. The company was formerly known as Soditech Ingenierie SA. Soditech SA was founded in 1990 and is headquartered in Aix-en-Provence, France.

CAC 40 ended the session with SODITECH sliding 8.54% to €1.50 on Monday while CAC 40 jumped 1.32% to €7,324.71.

Earnings Per Share

As for profitability, SODITECH has a trailing twelve months EPS of €0.13.

PE Ratio

SODITECH has a trailing twelve months price to earnings ratio of 11.54. Meaning, the purchaser of the share is investing €11.54 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.54%.

Moving Average

SODITECH’s worth is above its 50-day moving average of €1.50 and above its 200-day moving average of €1.49.

Volume

Today’s last reported volume for SODITECH is 300 which is 50.49% below its average volume of 606.

Revenue Growth

Year-on-year quarterly revenue growth declined by 12.7%, now sitting on 4.59M for the twelve trailing months.

More news about SODITECH.

5. SOLSTAD OFFSHORE (SOFF.OL)

-7.97% Price Change

Solstad Offshore ASA operates offshore service vessels and maritime services to offshore energy industry. It owns and operates platform supply vessel, anchor handling tug support vessel, and construction service vessels. The company offers subsea construction and renewable energy services, such as geotechnical work, walk to work services, grouting, SURF operations, cable laying and repair, trenching and burial, ROV support, installation of subsea equipment, survey work, IMR operations, node seismic operations, and diving and topside maintenance work. It operates a fleet of 27 construction service vessels, 20 anchor handling tug support vessels, and 39 platform supply vessels. The company was founded in 1964 and is headquartered in Skudeneshavn, Norway.

Oslo Børs Benchmark Index_GI ended the session with SOLSTAD OFFSHORE falling 7.97% to €17.66 on Monday while Oslo Børs Benchmark Index_GI jumped 1.21% to €1,246.85.

Earnings Per Share

As for profitability, SOLSTAD OFFSHORE has a trailing twelve months EPS of kr-8.21.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -32.03%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, SOLSTAD OFFSHORE’s stock is considered to be overbought (>=80).

More news about SOLSTAD OFFSHORE.

6. JINHUI SHIPP TRANS (JIN.OL)

-6.74% Price Change

Jinhui Shipping and Transportation Limited, an investment holding company, engages in ship chartering and owning activities internationally. The company provides ship management and shipping agent services, as well as engages in the money lending and property investment activities. It also owns a fleet of twenty four grabs fitted supramaxes and one chartered-in-panamax. The company was founded in 1987 and is based in Hong Kong, Hong Kong. Jinhui Shipping and Transportation Limited operates as a subsidiary of Jinhui Holdings Company Limited.

Oslo Børs Benchmark Index_GI ended the session with JINHUI SHIPP TRANS falling 6.74% to €5.95 on Monday while Oslo Børs Benchmark Index_GI jumped 1.21% to €1,246.85.

Earnings Per Share

As for profitability, JINHUI SHIPP TRANS has a trailing twelve months EPS of kr-3.77.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -9.16%.

Yearly Top and Bottom Value

JINHUI SHIPP TRANS’s stock is valued at kr5.95 at 22:40 EST, below its 52-week low of kr6.20.

Revenue Growth

Year-on-year quarterly revenue growth declined by 55.8%, now sitting on 134.26M for the twelve trailing months.

More news about JINHUI SHIPP TRANS.

7. TERACT (TRACT.PA)

-5.95% Price Change

Teract S.A. operates in retail business in Europe. The company operates through Garden Centre Retailer and Marketer segments. It operates garden centers and pet care shops under the Jardiland, Gamm vert, Delbard, and Jardinerie du Terroir brand names. The company also operates in the fresh, local, and organic produce sector under Frais d'Ici and Bio&Co brands with food outlets. It operates 1,597 stores. The company is based in Paris, France.

CAC 40 ended the session with TERACT falling 5.95% to €3.95 on Monday, after five successive sessions in a row of losses. CAC 40 rose 1.32% to €7,324.71, following the last session’s upward trend on what was an all-around positive trend exchanging session today.

Earnings Per Share

As for profitability, TERACT has a trailing twelve months EPS of €0.62.

PE Ratio

TERACT has a trailing twelve months price to earnings ratio of 6.37. Meaning, the purchaser of the share is investing €6.37 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 27.74%.

Yearly Top and Bottom Value

TERACT’s stock is valued at €3.95 at 22:40 EST, way below its 52-week low of €5.38.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, TERACT’s stock is considered to be overbought (>=80).

Moving Average

TERACT’s value is way below its 50-day moving average of €5.92 and way below its 200-day moving average of €6.15.

Volatility

TERACT’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.71%, a negative 0.86%, and a positive 1.74%.

TERACT’s highest amplitude of average volatility was 0.71% (last week), 1.60% (last month), and 1.74% (last quarter).

More news about TERACT.

8. PGS (PGS.OL)

-5.82% Price Change

PGS ASA, together with its subsidiaries, operates as a marine geophysical company primarily in Norway. The company provides a range of seismic and reservoir services, including data acquisition, imaging, interpretation, and field evaluation to oil and gas companies, as well as carbon storage and offshore wind markets. It also operates in the Asia Pacific, Canada, Egypt, the Americas, Angola, the United Kingdom, Greece, Cyprus, Ukraine, Brazil, South Africa, other African countries, the Middle East, and internationally. The company was formerly known as Petroleum Geo-Services ASA and changed its name to PGS ASA in May 2019. PGS ASA was founded in 1991 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with PGS falling 5.82% to €7.28 on Monday while Oslo Børs Benchmark Index_GI jumped 1.21% to €1,246.85.

Earnings Per Share

As for profitability, PGS has a trailing twelve months EPS of kr-0.74.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -18.17%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 43%, now sitting on 714.3M for the twelve trailing months.

Growth Estimates Quarters

The company’s growth estimates for the present quarter is a negative 38.9% and positive 700% for the next.

Yearly Top and Bottom Value

PGS’s stock is valued at kr7.28 at 22:40 EST, way below its 52-week high of kr13.15 and way above its 52-week low of kr4.88.

More news about PGS.

9. NAPATECH (NAPA.OL)

-5.79% Price Change

Napatech A/S offers reconfigurable computing solutions for the networking and cybersecurity applications worldwide. The company provides Link Capture Software that enables packet capture with nanosecond timestamping and replay with precise inter-frame gap control; Link Inline Software, which offers a processing architecture that offloads and accelerates flow aware application data planes; Link Virtualization Software that offloads and accelerates the Open vSwitch data plane to enhance CPU efficiency and network performance; and Link Programmable, which enables end users and OEMs to deploy FPGA computation solutions. It also offers solutions for telecom operators, cloud and data center service providers, and infrastructure and defense, as well as financial services, cyber security, network management, and virtualization. The company was incorporated in 2003 and is headquartered in Copenhagen, Denmark.

Oslo Børs Benchmark Index_GI ended the session with NAPATECH sliding 5.79% to €9.12 on Monday while Oslo Børs Benchmark Index_GI rose 1.21% to €1,246.85.

Earnings Per Share

As for profitability, NAPATECH has a trailing twelve months EPS of kr-1.15.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -57.61%.

More news about NAPATECH.

10. MDXHEALTH (MDXH.BR)

-5.56% Price Change

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which provide physicians with a clinical pathway to identify clinically prostate cancer while minimizing the use of invasive procedures that are prone to complications. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium.

BEL 20 ended the session with MDXHEALTH dropping 5.56% to €0.31 on Monday, after two sequential sessions in a row of losses. BEL 20 jumped 0.86% to €3,653.47, following the last session’s upward trend on what was a somewhat up trend trading session today.

Earnings Per Share

As for profitability, MDXHEALTH has a trailing twelve months EPS of €-0.22.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -171.13%.

Yearly Top and Bottom Value

MDXHEALTH’s stock is valued at €0.31 at 22:40 EST, way below its 52-week high of €0.85 and way higher than its 52-week low of €0.26.

Moving Average

MDXHEALTH’s worth is below its 50-day moving average of €0.33 and way below its 200-day moving average of €0.43.

Revenue Growth

Year-on-year quarterly revenue growth grew by 142.6%, now sitting on 55.49M for the twelve trailing months.

Earnings Before Interest, Taxes, Depreciation, and Amortization

MDXHEALTH’s EBITDA is 1.6.

More news about MDXHEALTH.

Stay up to date with our winners and losers daily report